Literature DB >> 11115059

Retinal vein thrombosis associated with chronic hepatitis C: a case series and review of the literature.

A Nadir1, A Amin, N Chalisa, D H van Thiel.   

Abstract

The role of procoagulant autoantibodies in hepatitis C virus (HCV) infection is unclear. Three individuals with HCV infection and a unique genetic hypercoagulable state developed retinal vein thrombosis (RVT) in association with interferon-alpha (IFN-alpha) therapy. It is probable that a combination of active HCV infection in a genetically susceptible individual receiving IFN-alpha accounted for the observed RVT.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11115059     DOI： 10.1046/j.1365-2893.2000.00245.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN： 1352-0504            Impact factor:   3.728


  13 in total

1.  [Acute loss of vision during therapy of chronic hepatitis C].

Authors:  J P Salgado; R Khoramnia; M M Maier; C P Lohmann; C Winkler von Mohrenfels
Journal:  Ophthalmologe       Date:  2011-06       Impact factor: 1.059

2.  Branch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C.

Authors:  Luciana Lofego Goncalves; Alberto Queiroz Farias; Patrícia Lofego Gonçalves; Elbio-Antonio D'Amico; Flair José Carrilho
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

3.  Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C.

Authors:  Iman Zandieh; Mohamed Adenwalla; Cindy Cheong-Lee; Patrick E Ma; Eric M Yoshida
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

Review 4.  Interferon-associated retinopathy risk in patients with diabetes and hypertensive hepatitis C.

Authors:  Ji-Hua Xue; Hai-Hong Zhu; Jing Wang; Zhi Chen
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

5.  A case of deep venous thrombosis associated with pegylated interferon alpha2b plus ribavirin treatment of chronic hepatitis C.

Authors:  Chiaki Okuse; Kayo Adachi; Yoshiki Katakura; Kotaro Matsunaga; Toshiya Ishii; Nobuyuki Matsumoto; Hiroshi Yotsuyanagi; Shiro Iino; Michihiro Suzuki; Fumio Itoh
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

Review 6.  Systematic review of case reports of antiphospholipid syndrome following infection.

Authors:  N Abdel-Wahab; M A Lopez-Olivo; G P Pinto-Patarroyo; M E Suarez-Almazor
Journal:  Lupus       Date:  2016-04-07       Impact factor: 2.911

Review 7.  Ischemic colitis during interferon-ribavirin therapy for chronic hepatitis C: a case report.

Authors:  Su Jung Baik; Tae Hun Kim; Kwon Yoo; Il Hwan Moon; Min-Sun Cho
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

8.  Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C.

Authors:  Damien Sene; Valerie Touitou; Bahram Bodaghi; David Saadoun; Gabriel Perlemuter; Nathalie Cassoux; Jean-Charles Piette; Phuc-Le Hoang; Patrice Cacoub
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

9.  Cerebral venous thrombosis after high dose steroid in multiple sclerosis: a case report.

Authors:  S Gazioglu; D Solmaz; C Boz
Journal:  Hippokratia       Date:  2013-01       Impact factor: 0.471

10.  Cerebral venous thrombosis as an extrahepatic manifestation of acute anicteric hepatitis a infection.

Authors:  Panagiotis Zis; Elli Kontogeorgi; Dimitrios Karakalos; Despoina Pavlopoulou; Vassilios A Sevastianos
Journal:  Case Rep Neurol Med       Date:  2012-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.